Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever
- PMID: 12147378
- DOI: 10.1016/S0140-6736(02)09522-3
Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever
Abstract
In Iquitos, Peru, no cases of dengue haemorrhagic fever have been recorded in individuals infected with dengue-1 virus followed by American genotype dengue-2 (American dengue-2) virus. We assayed serum samples collected in Iquitos that tested positive for antibodies of monotype dengue-1 and monotype dengue-2 using a plaque reduction neutralisation test to determine their ability to neutralise the infectivity of two dengue-1 viruses, two American dengue-2 viruses, and two Asian dengue-2 viruses. Sera positive for the dengue-1 antibody neutralised dengue-1 viruses and American dengue-2 viruses much more effectively than Asian dengue-2 viruses. Neutralisation of American dengue-2 virus by sera positive for dengue-1 antibodies may account for the absence of dengue haemorrhagic fever in individuals infected with dengue-1 in 1990-91 followed by American dengue-2 virus in 1995 in Iquitos, Peru.
Similar articles
-
Antibodies against thrombin in dengue patients contain both anti-thrombotic and pro-fibrinolytic activities.Thromb Haemost. 2013 Aug;110(2):358-65. doi: 10.1160/TH13-02-0149. Epub 2013 Jun 6. Thromb Haemost. 2013. PMID: 23740201
-
A review of dengue fever: a resurging tropical disease.Pediatr Emerg Care. 2013 May;29(5):665-9; quiz 670-1. doi: 10.1097/PEC.0b013e31828ed30e. Pediatr Emerg Care. 2013. PMID: 23640151 Review.
-
Cross-serotype neutralization of dengue virus in Aotus nancymae monkeys.J Infect Dis. 2005 Mar 15;191(6):1000-4. doi: 10.1086/427511. Epub 2005 Jan 31. J Infect Dis. 2005. PMID: 15717278
-
Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever.Lancet. 1999 Oct 23;354(9188):1431-4. doi: 10.1016/S0140-6736(99)04015-5. Lancet. 1999. PMID: 10543670
-
Pathogenesis of dengue: challenges to molecular biology.Science. 1988 Jan 29;239(4839):476-81. doi: 10.1126/science.3277268. Science. 1988. PMID: 3277268 Review.
Cited by
-
Is new dengue vaccine efficacy data a relief or cause for concern?NPJ Vaccines. 2023 Apr 15;8(1):55. doi: 10.1038/s41541-023-00658-2. NPJ Vaccines. 2023. PMID: 37061527 Free PMC article. Review.
-
IL-18: The Forgotten Cytokine in Dengue Immunopathogenesis.J Immunol Res. 2021 Nov 19;2021:8214656. doi: 10.1155/2021/8214656. eCollection 2021. J Immunol Res. 2021. PMID: 34840991 Free PMC article. Review.
-
Antigenic evolution of dengue viruses over 20 years.Science. 2021 Nov 19;374(6570):999-1004. doi: 10.1126/science.abk0058. Epub 2021 Nov 18. Science. 2021. PMID: 34793238 Free PMC article.
-
Nationwide Distribution of Dengue Virus Type 3 (DENV-3) Genotype I and Emergence of DENV-3 Genotype III during the 2019 Outbreak in Bangladesh.Trop Med Infect Dis. 2021 Apr 21;6(2):58. doi: 10.3390/tropicalmed6020058. Trop Med Infect Dis. 2021. PMID: 33919249 Free PMC article.
-
Mobilization and Activation of the Innate Immune Response to Dengue Virus.Front Cell Infect Microbiol. 2020 Nov 3;10:574417. doi: 10.3389/fcimb.2020.574417. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 33224897 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical